BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 15147989)

  • 1. Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds.
    Ehrlich HP
    Am J Surg; 2004 May; 187(5A):29S-33S. PubMed ID: 15147989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of dermal-epidermal skin equivalents ('composite-skin') of human keratinocytes in a collagen-glycosaminoglycan matrix(Integra artificial skin).
    Kremer M; Lang E; Berger AC
    Br J Plast Surg; 2000 Sep; 53(6):459-65. PubMed ID: 10927672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes.
    Spiekstra SW; Breetveld M; Rustemeyer T; Scheper RJ; Gibbs S
    Wound Repair Regen; 2007; 15(5):708-17. PubMed ID: 17971017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of human fibroblasts on development and quality of multilayered composite grafts in athymic nude mice.
    Cedidi CC; Wilkens L; Berger A; Ingianni G
    Eur J Med Res; 2007 Nov; 12(11):541-55. PubMed ID: 18024263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of an engraftable skin equivalent based on matriderm with human keratinocytes and fibroblasts].
    Golinski PA; Zöller N; Kippenberger S; Menke H; Bereiter-Hahn J; Bernd A
    Handchir Mikrochir Plast Chir; 2009 Dec; 41(6):327-32. PubMed ID: 19711256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cultured keratinocytes and dermal fibroblasts on a double-layer scaffold with bi-medium culture system.
    Huang YC; Wang TW; Sun JS; Lin FH
    Biomed Sci Instrum; 2003; 39():500-5. PubMed ID: 12724942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation.
    Lamme EN; Van Leeuwen RT; Brandsma K; Van Marle J; Middelkoop E
    J Pathol; 2000 Apr; 190(5):595-603. PubMed ID: 10727986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suitability of cells from different tissues for use in tissue-engineered skin substitutes.
    van den Bogaerdt AJ; van Zuijlen PP; van Galen M; Lamme EN; Middelkoop E
    Arch Dermatol Res; 2002 May; 294(3):135-42. PubMed ID: 12029501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culture of keratinocytes for transplantation without the need of feeder layer cells.
    Coolen NA; Verkerk M; Reijnen L; Vlig M; van den Bogaerdt AJ; Breetveld M; Gibbs S; Middelkoop E; Ulrich MM
    Cell Transplant; 2007; 16(6):649-61. PubMed ID: 17912956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal cells from subcutaneous adipose tissue seeded in a native collagen/elastin dermal substitute reduce wound contraction in full thickness skin defects.
    de Vries HJ; Middelkoop E; van Heemstra-Hoen M; Wildevuur CH; Westerhof W
    Lab Invest; 1995 Oct; 73(4):532-40. PubMed ID: 7474925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Apligraf in acute wounds.
    Kirsner RS
    J Dermatol; 1998 Dec; 25(12):805-11. PubMed ID: 9990773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new dermal equivalent: the use of dermal fibroblast culture alone without exogenous materials.
    Lee DY; Lee JH; Yang JM; Lee ES; Park KH; Mun GH
    J Dermatol Sci; 2006 Aug; 43(2):95-104. PubMed ID: 16687242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of animal-derived collagen matrix by human fibroblast-derived dermal matrix for human skin equivalent products.
    El Ghalbzouri A; Commandeur S; Rietveld MH; Mulder AA; Willemze R
    Biomaterials; 2009 Jan; 30(1):71-8. PubMed ID: 18838164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gelatin-chondroitin sulfate-hyaluronic acid skin substitute on wound healing in SCID mice.
    Wang TW; Sun JS; Wu HC; Tsuang YH; Wang WH; Lin FH
    Biomaterials; 2006 Nov; 27(33):5689-97. PubMed ID: 16908060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a composite skin graft composed of cultured human keratinocytes and fibroblasts and a collagen-GAG matrix to cover full-thickness wounds on athymic mice.
    Cooper ML; Hansbrough JF
    Surgery; 1991 Feb; 109(2):198-207. PubMed ID: 1992553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wound healing effect of acellular artificial dermis containing extracellular matrix secreted by human skin fibroblasts.
    Seo YK; Song KY; Kim YJ; Park JK
    Artif Organs; 2007 Jul; 31(7):509-20. PubMed ID: 17584475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular artificial skin substitute produced by short period simultaneous culture of fibroblasts and keratinocytes.
    Kim BM; Suzuki S; Nishimura Y; Um SC; Morota K; Maruguchi T; Ikada Y
    Br J Plast Surg; 1999 Oct; 52(7):573-8. PubMed ID: 10658112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Skin substitutes reconstructed in the laboratory: application in burn treatment].
    Braye F; Hautier A; Bouez C; Damour O
    Pathol Biol (Paris); 2005 Dec; 53(10):613-7. PubMed ID: 16364813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new system for cultivation of human keratinocytes on acellular dermal matrix substitute with the use of human fibroblast feeder layer.
    Xiao S; Zhu S; Ma B; Xia ZF; Yang J; Wang G
    Cells Tissues Organs; 2008; 187(2):123-30. PubMed ID: 17940330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of artificial dermal substitute, cultured keratinocytes and split thickness skin graft on wound contraction.
    Reid MJ; Currie LJ; James SE; Sharpe JR
    Wound Repair Regen; 2007; 15(6):889-96. PubMed ID: 18028138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.